Plunkett Research Online: ADMA Biologics Inc

ADMA BIOLOGICS INC (ADMA:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

ADMA Biologics Inc is a United States-based biopharmaceutical company. It is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. The company develops and manufactures specialty plasma-based biologics for the proposed treatment of immune deficiencies and .....



ADMA Biologics Inc
Ticker: ADMA
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 201 478-5552
Fax: 201 478-5553
Address: 465 State Route 17
Ramsey, NJ 07446 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Adam GrossmanCEO/Director/Founder/President
Brian LenzCFO/Chief Accounting Officer/Vice President
See More
ADMA Biologics Inc is a United States-based biopharmaceutical company. It is engaged in the development and commercialization of human plasma and plasma-derived therapeutics. The company develops and manufactures specialty plasma-based biologics for the proposed treatment of immune deficiencies and .....See More See More

Auditor: CohnReznick LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201120102017201620152014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: